Cargando…
Autophagy Takes Center Stage as a Possible Cancer Hallmark
Cancer remains one of the leading causes of death worldwide, despite significant advances in cancer research and improvements in anticancer therapies. One of the major obstacles to curing cancer is the difficulty of achieving the complete annihilation of resistant cancer cells. The resistance of can...
Autores principales: | Alvarez-Meythaler, Jose G., Garcia-Mayea, Yoelsis, Mir, Cristina, Kondoh, Hiroshi, LLeonart, Matilde E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643020/ https://www.ncbi.nlm.nih.gov/pubmed/33194736 http://dx.doi.org/10.3389/fonc.2020.586069 |
Ejemplares similares
-
Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021) -
The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021) -
Five microRNAs in Serum Are Able to Differentiate Breast Cancer Patients From Healthy Individuals
por: Feliciano, Andrea, et al.
Publicado: (2020) -
Editorial: How Do Metabolism, Angiogenesis, and Hypoxia Modulate Resistance?
por: Kondoh, Hiroshi, et al.
Publicado: (2021) -
Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022)